Treatment of type 2 diabetes with rosiglitazone associated with increased risk of cardiovascular events among older adults

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2008年 / 43卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：79 / 80
页数：2
相关论文
共 50 条
  • [31] Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes
    Mangla, Neeraj
    Ajmera, Veeral H.
    Caussy, Cyrielle
    Sirlin, Claude
    Brouha, Sharon
    Bajwa-Dulai, Sonia
    Madamba, Egburt
    Bettencourt, Ricki
    Richards, Lisa
    Loomba, Rohit
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (03) : 744 - +
  • [32] Risk Models for the Development of Cardiovascular and Microvascular Events in Adults with Type 2 Diabetes in the FIELD Study
    Ong, Kwok Leung
    O'Connell, Rachel L.
    Januszewski, Andrzej S.
    Donoghoe, Mark W.
    Gebski, Val
    Sullivan, David
    Rye, Kerry Ann
    Scott, Russell S.
    Best, James D.
    Taskinen, Marja-Riitta
    Simes, Robert J.
    Jenkins, Alicia
    Keech, Anthony C.
    DIABETES, 2023, 72
  • [33] EFFECTS OF OBESITY AND TYPE 2 DIABETES ON THE 30 YEAR RISK OF CARDIOVASCULAR EVENTS IN YOUNG ADULTS
    Khoury, P. R.
    Daniels, S. R.
    Kimball, T. R.
    Urbina, E. M.
    Dolan, L. H.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S307 - S307
  • [34] Higher circulating omentin is associated with increased risk of primary cardiovascular events in type 2 diabetes: results from the ESTHER study
    Niersmann, C.
    Carstensen-Kirberg, M.
    Maalmi, H.
    Holleczek, B.
    Roden, M.
    Brenner, H.
    Herder, C.
    Schoettker, B.
    DIABETOLOGIA, 2019, 62 : S64 - S65
  • [35] Walking and type 2 diabetes risk using CANRISK scores among older adults
    Johnson, Steven T.
    Eurich, Dean T.
    Lytvyak, Ellina
    Mladenovic, Ana
    Taylor, Lorian M.
    Johnson, Jeffrey A.
    Vallance, Jeff K.
    APPLIED PHYSIOLOGY NUTRITION AND METABOLISM, 2017, 42 (01) : 33 - 38
  • [36] Thiazolidinedione treatment is not associated with an increased risk of major adverse cardiovascular events
    Bilik, Dorian
    McEwen, Laura N.
    Selby, Joe V.
    Marrero, David G.
    Brown, Arleen F.
    Herman, William H.
    DIABETES, 2008, 57 : A85 - A85
  • [37] Lipoprotein(a) concentration is associated with risk of type 2 diabetes and cardiovascular events in a Chinese population with very high cardiovascular risk
    Dilidaer Muhanhali
    Tianyu Zhai
    Zhenqin Cai
    Yan Ling
    Endocrine, 2020, 69 : 63 - 72
  • [38] Medication Adherence and Its Associated Determinants in Older Adults with Type 2 Diabetes and Cardiovascular Comorbidities
    Al-Azayzih, Ahmad
    Kanaan, Roaa J.
    Altawalbeh, Shoroq M.
    Al-Qerem, Walid
    Smadi, Saja
    PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 3107 - 3118
  • [39] Lipoprotein(a) concentration is associated with risk of type 2 diabetes and cardiovascular events in a Chinese population with very high cardiovascular risk
    Muhanhali, Dilidaer
    Zhai, Tianyu
    Cai, Zhenqin
    Ling, Yan
    ENDOCRINE, 2020, 69 (01) : 63 - 72
  • [40] Control of Cardiovascular Risk Factors Among US Adults With Type 2 Diabetes With and Without Cardiovascular Disease
    Andary, Rana
    Fan, Wenjun
    Wong, Nathan D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 (04): : 522 - 527
12345